NFE2L2 and non-small cell lung carcinoma: NFE2L2/KEAP1 is a commonly mutated signaling pathway in NSCLC sub-types [95] and GOF mutations of NFE2L2 or LOF mutations of KEAP1 have been often seen in this kind of malignancy [13].